anonymous
Guest
anonymous
Guest
Lets see? Who is the right Tildra patient--
1. Person who has psoriasis and has not responded to any topical or biologic agent?
2. Person who wants to pay for specificity that has no proven benefits?
3. A person who does not want to go on a biologic because SUN cannot deliver the medication through the HUB for several months
4. Person being treated by dermatologists who do not know what they are doing?
5. Person who wants to pay full retail price because their coverage will not be in place for a year?
6. Relative or close friend to one of our TMs?
I'd say 4 and 6 define the best niche for Tildra.
That should be about 200-300 patients in total over the first year.
Cannot be employees. Better check, the SUN drug plan probably does not cover Ilumya. Too expensive.